EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C21H16ClF3N4O3 |
| Net Charge | 0 |
| Average Mass | 464.831 |
| Monoisotopic Mass | 464.08630 |
| SMILES | CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1 |
| InChI | InChI=1S/C21H16ClF3N4O3/c1-26-19(30)18-11-15(8-9-27-18)32-14-5-2-12(3-6-14)28-20(31)29-13-4-7-17(22)16(10-13)21(23,24)25/h2-11H,1H3,(H,26,30)(H2,28,29,31) |
| InChIKey | MLDQJTXFUGDVEO-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Roles: | anticoronaviral agent Any antiviral agent which inhibits the activity of coronaviruses. EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor An EC 2.7.11.* (protein-serine/threonine kinase) inhibitor that interferes with the action of non-specific serine/threonine protein kinase (EC 2.7.11.1), a kinase enzyme involved in phosphorylation of hydroxy group of serine or threonine. tyrosine kinase inhibitor Any protein kinase inhibitor that interferes with the action of tyrosine kinase. ferroptosis inducer Any substance that induces or promotes ferroptosis (a type of programmed cell death dependent on iron and characterized by the accumulation of lipid peroxides) in organisms. |
| Applications: | angiogenesis inhibitor An agent and endogenous substances that antagonize or inhibit the development of new blood vessels. renoprotective agent Any compound that is able to prevent damage to the kidneys. antihypertensive agent Any drug used in the treatment of acute or chronic vascular hypertension regardless of pharmacological mechanism. anticoagulant An agent that prevents blood clotting. hypoglycemic agent A drug which lowers the blood glucose level. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| sorafenib (CHEBI:50924) has role angiogenesis inhibitor (CHEBI:48422) |
| sorafenib (CHEBI:50924) has role anticoagulant (CHEBI:50249) |
| sorafenib (CHEBI:50924) has role anticoronaviral agent (CHEBI:149553) |
| sorafenib (CHEBI:50924) has role antihypertensive agent (CHEBI:35674) |
| sorafenib (CHEBI:50924) has role antineoplastic agent (CHEBI:35610) |
| sorafenib (CHEBI:50924) has role EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor (CHEBI:50925) |
| sorafenib (CHEBI:50924) has role ferroptosis inducer (CHEBI:173085) |
| sorafenib (CHEBI:50924) has role hypoglycemic agent (CHEBI:35526) |
| sorafenib (CHEBI:50924) has role renoprotective agent (CHEBI:231911) |
| sorafenib (CHEBI:50924) has role tyrosine kinase inhibitor (CHEBI:38637) |
| sorafenib (CHEBI:50924) is a (trifluoromethyl)benzenes (CHEBI:83565) |
| sorafenib (CHEBI:50924) is a aromatic ether (CHEBI:35618) |
| sorafenib (CHEBI:50924) is a monochlorobenzenes (CHEBI:83403) |
| sorafenib (CHEBI:50924) is a phenylureas (CHEBI:134043) |
| sorafenib (CHEBI:50924) is a pyridinecarboxamide (CHEBI:25529) |
| Incoming Relation(s) |
| sorafenib tosylate (CHEBI:50928) has part sorafenib (CHEBI:50924) |
| IUPAC Name |
|---|
| 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide |
| INNs | Source |
|---|---|
| sorafenib | WHO MedNet |
| sorafenib | WHO MedNet |
| sorafénib | WHO MedNet |
| sorafenibum | WHO MedNet |
| Synonyms | Source |
|---|---|
| 4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide | ChemIDplus |
| BAY-43-9006 | ChEMBL |
| N-(4-Chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea | ChemIDplus |
| Citations |
|---|